Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Warfarin-induced skin necrosis

Catherine R Mungalsingh, Jamie Bomford, Jeremy Nayagam, Mirella Masiello, Ugo I Ekeowa and Simon Webster
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.12-1-90
Clin Med February 2012
Catherine R Mungalsingh
Chest Unit, Kent and Sussex Hospital, Tunbridge Wells, Kent
Roles: CT1
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jamie Bomford
Chest Unit, Kent and Sussex Hospital, Tunbridge Wells, Kent
Roles: FY2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy Nayagam
Chest Unit, Kent and Sussex Hospital, Tunbridge Wells, Kent
Roles: FY1
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mirella Masiello
Chest Unit, Kent and Sussex Hospital, Tunbridge Wells, Kent
Roles: FY1
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ugo I Ekeowa
Chest Unit, Kent and Sussex Hospital, Tunbridge Wells, Kent
Roles: Specialist registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Webster
Chest Unit, Kent and Sussex Hospital, Tunbridge Wells, Kent
Roles: Consultant in respiratory medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: simonwebster1@nhs.net
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

Warfarin-induced skin necrosis is a rare but serious complication of treatment with this commonly prescribed drug. This lesson presents the case of a patient with extensive skin necrosis after inappropriately prolonged warfarinisation and delayed recognition. The condition is briefly reviewed to highlight key features and risk factors.

Lesson

A malnourished 82-year-old woman was referred to the emergency department with an extensive, painful rash. This had worsened despite two weeks treatment for herpes zoster. A month prior to admission she had undergone patellar surgery with a brief interruption of warfarin treatment. Warfarinisation had been commenced a year previously for a postoperative pulmonary embolus. Examination revealed extensive tender and malodorous erythematous plaques with a violacious hue. Central necrotic eschars and vesiculobullous changes were evident and there was involvement of the face, breasts, trunk and limbs (Fig 1).

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

Multiple tender, malodorous necrotic lesions were found on the patient's trunks, limbs and face. Right panel: these were typically comprised an eschar with surrounding purpura. Approximately 20% of the patient's body surface area was eventually involved.

Warfarin-induced skin necrosis (WISN) was suspected necessitating the cessation of warfarin, and administration of vitamin K and low molecular weight heparin. Broad-spectrum antibiotics, enteral feeding and a three-day course of methylprednisolone, as vasculitis could not be excluded, were commenced. Biopsy of involved skin showed vascular thrombi, patchy necrosis and recent haemorrhage consistent with WISN. No evidence of Warfarin-induced skin necrosis vasculitis was seen. The erythematous plaques progressively became entirely necrotic. Despite prolonged treatment with intravenous antibiotics, the patient died from overwhelming sepsis and multi-organ failure.

Discussion

WISN typically occurs in obese middle-aged women. Lesions have a propensity for areas with increased subcutaneous fat and classically appear on the breast, buttocks, thighs and abdomen.1–4 In the majority, lesions develop 3–6 days after starting warfarin therapy,1,2,4–8 although cases are reported after up to three years.5,7 Affected skin undergoes infarction evolving to necrotic eschar and full thickness skin loss.1–4,8 Clinical history and cutaneous distribution in conjunction with histology helps distinguish WISN from other conditions such as heparin-induced skin necrosis, disseminated intravascular coagulation and necrotising fasciitis.1

Implicated aetiological mechanisms include protein C deficiency, hypersensitivity and a direct toxic effect of warfarin.1,2,8 Histology typically shows diffuse microthrombi within dermal and subcutaneous capillaries, venules and deep veins, with endothelial cell damage resulting in ischaemic skin necrosis and red blood cell extravasation.1 The lack of perivascular inflammation and arteriolar thrombosis, differentiates WISN from the vasculitides.1,3

The mainstay of management is supportive. Treatment is aimed at withdrawing warfarin and reversing its effect on protein C with vitamin K and fresh frozen plasma.1–9 Heparin therapy is utilised to prevent further thrombosis in the postcapillary venules,4 and protein C concentrate is effective although high cost has limited its use. Patients may require local debridement and occasionally skin grafting or even amputation.2 The main causes of death are deep tissue necrosis, sepsis syndrome secondary to wound infection and multi-organ failure.11

Lessons to be elicited

One per cent of the UK population take warfarin.11,12 WISN is a rare but important complication that requires high clinical suspicion and early recognition. Timely initiation of treatment may prevent extensive skin involvement and predisposition to overwhelming bacterial infection. Moreover, this case highlights the importance of determining treatment interval at initiation of anticoagulation and subsequently reviewing the indication for its continuation in all anticoagulated patients encountered in medical practice.

  • © 2012 Royal College of Physicians

References

  1. ↵
    1. Nazarian R,
    2. Van Cott E,
    3. Zembowicz A,
    4. Duncan LM
    . Warfarin-induced skin necrosis. J Am Acad Dermatol 2009; 61: 325–32doi:10.1016/j.jaad.2008.12.039
    OpenUrlCrossRefPubMed
  2. ↵
    1. Mo J,
    2. Retzinger GS
    . Warfarin-induced skin necrosis. Lab lines–a publication of the Department of Pathology and Laboratory Medicine at the University of Cincinnati20017
  3. ↵
    1. Pero M,
    2. Verma S,
    3. Espeso A,
    4. Griffiths M,
    5. Jani P
    . An unusual case of warfarin-induced pinna skin necrosis. J Laryngol Otol 2009; 123: 685–8
    OpenUrlPubMed
  4. ↵
    1. Gelwix T,
    2. Beeson M
    . Warfarin-induced skin necrosis. Am J Emerg Med 1998; 165541–3doi:10.1016/S0735-6757(98)90015-8
    OpenUrlCrossRefPubMed
  5. ↵
    1. Essex DW,
    2. Wynn SS,
    3. Jin DK
    . Late onset warfain-induced skin necrosis: case report and review of the literature. Am J Hematol 1998; 57: 233–7
    OpenUrlCrossRefPubMed
    1. Cole MS,
    2. Minifee PK,
    3. Wolma FJ
    . Coumarin necrosis: a review of the literature. Surgery 1988; 103: 271–7
    OpenUrlPubMed
  6. ↵
    1. Sorensen D,
    2. Eilbert W
    . Warfarin-induced skin necrosis. Ann Emerg Med 2010; 55: 302–5
    OpenUrlPubMed
  7. ↵
    1. Beitz J
    . Wound wise–anticoagulant-induced skin necrosis. Am J Nurs 2004; 104: 31–2
    OpenUrlPubMed
  8. ↵
    1. Stewart A,
    2. Penman I,
    3. Cook M,
    4. Ludlam C
    . Short report: warfarin-induced skin necrosis. Postgrad Med J 1999; 75: 233–5
    OpenUrlAbstract/FREE Full Text
    1. Bhaijee F,
    2. Wainwright H,
    3. Meintjes G,
    4. et al
    . Warfarin-induced skin necrosis in HIV-1-infected patients with tuberculosis and venous thrombosis. S Afr Med J 2010; 100: 372–7
    OpenUrlPubMed
  9. ↵
    1. Kamali F,
    2. Pirmohamed M
    . The future prospects of pharmacogenetics in oral anticoagulation therapy. Br J Clin Pharmacol 2006; 616: 746–51doi:10.1111/j.1365-2125.2006.02679.x
    OpenUrlCrossRef
  10. ↵
    1. Wadelius M,
    2. Pirmohamed M
    . Pharmacogenetics of warfarin: current status and future challenges. Pharmacogenomics J 2007; 7: 99–111doi:10.1038/sj.tpj.6500417
    OpenUrlCrossRefPubMed
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Warfarin-induced skin necrosis
Catherine R Mungalsingh, Jamie Bomford, Jeremy Nayagam, Mirella Masiello, Ugo I Ekeowa, Simon Webster
Clinical Medicine Feb 2012, 12 (1) 90-91; DOI: 10.7861/clinmedicine.12-1-90

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Warfarin-induced skin necrosis
Catherine R Mungalsingh, Jamie Bomford, Jeremy Nayagam, Mirella Masiello, Ugo I Ekeowa, Simon Webster
Clinical Medicine Feb 2012, 12 (1) 90-91; DOI: 10.7861/clinmedicine.12-1-90
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Lesson
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Lesson of the month 2: A case of coma in a Parkinson's patient: a combination of fatigue, dehydration and high protein diet over the New Year period?
  • Lesson of the month 2: Toxic shock syndrome
  • Lesson of the month (2): All that glitters is not stroke
Show more Lesson of the month (2)

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians